Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate West Nile Virus Clearance

J Virol. 2016 Dec 16;91(1):e01529-16. doi: 10.1128/JVI.01529-16. Print 2017 Jan 1.

Abstract

CD8+ T cells are crucial components of immunity and play a vital role in recovery from West Nile virus (WNV) infection. Here, we identify a previously unrecognized function of interleukin-17A (IL-17A) in inducing cytotoxic-mediator gene expression and promoting CD8+ T cell cytotoxicity against WNV infection in mice. We find that IL-17A-deficient (Il17a-/-) mice are more susceptible to WNV infection and develop a higher viral burden than wild-type (WT) mice. Interestingly, the CD8+ T cells isolated from Il17a-/- mice are less cytotoxic and express lower levels of cytotoxic-mediator genes, which can be restored by supplying recombinant IL-17A in vitro and in vivo Importantly, treatment of WNV-infected mice with recombinant IL-17A, as late as day 6 postinfection, significantly reduces the viral burden and increases survival, suggesting a therapeutic potential for IL-17A. In conclusion, we report a novel function of IL-17A in promoting CD8+ T cell cytotoxicity, which may have broad implications in other microbial infections and cancers.

Importance: Interleukin-17A (IL-17A) and CD8+ T cells regulate diverse immune functions in microbial infections, malignancies, and autoimmune diseases. IL-17A is a proinflammatory cytokine produced by diverse cell types, while CD8+ T cells (known as cytotoxic T cells) are major cells that provide immunity against intracellular pathogens. Previous studies have demonstrated a crucial role of CD8+ T cells in recovery from West Nile virus (WNV) infection. However, the role of IL-17A during WNV infection remains unclear. Here, we demonstrate that IL-17A protects mice from lethal WNV infection by promoting CD8+ T cell-mediated clearance of WNV. In addition, treatment of WNV-infected mice with recombinant IL-17A reduces the viral burden and increases survival of mice, suggesting a potential therapeutic. This novel IL-17A-CD8+ T cell axis may also have broad implications for immunity to other microbial infections and cancers, where CD8+ T cell functions are crucial.

Keywords: CD8 T cell; IL-17A; West Nile virus.

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / immunology
  • Brain / virology
  • Cytotoxicity, Immunologic / drug effects*
  • Female
  • Gene Expression
  • Humans
  • Interleukin-17 / genetics
  • Interleukin-17 / immunology
  • Interleukin-17 / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • Neurons / drug effects
  • Neurons / immunology
  • Neurons / virology
  • Primary Cell Culture
  • Receptors, Interleukin-17 / genetics
  • Receptors, Interleukin-17 / immunology
  • Recombinant Proteins / genetics
  • Recombinant Proteins / immunology
  • Recombinant Proteins / pharmacology
  • Survival Analysis
  • T-Lymphocytes, Cytotoxic / drug effects*
  • T-Lymphocytes, Cytotoxic / immunology
  • T-Lymphocytes, Cytotoxic / virology
  • Treatment Outcome
  • Viral Load / drug effects
  • Virus Replication / drug effects
  • West Nile Fever / drug therapy*
  • West Nile Fever / immunology
  • West Nile Fever / mortality
  • West Nile Fever / virology
  • West Nile virus / drug effects*
  • West Nile virus / genetics
  • West Nile virus / growth & development

Substances

  • Il17a protein, mouse
  • Il17ra protein, mouse
  • Interleukin-17
  • Receptors, Interleukin-17
  • Recombinant Proteins